You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Small lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

Not yet recruiting
  • Elderly Patients
  • Metastatic Lung Cancer
  • Single drug chemotherapy plus immunotherapy
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 15, 2023

Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Port Saint Lucie, Florida
  • +1 more
Aug 11, 2023

NSCLC Trial in Guangzhou (BL-M07D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 1, 2023

NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tislelizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2023

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • (no location specified)
May 8, 2023

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy

Not yet recruiting
  • Non-small Cell Lung Cancer Metastatic
    • (no location specified)
    Sep 13, 2023

    NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Tirelizumab；Chemotherapy monotherapy
    • (no location specified)
    Jul 27, 2023

    Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

    Recruiting
    • Cancer
    • +11 more
    • San Antonio, Texas
      South Texas Accelerated Research Therapeutics, LLC
    Jun 21, 2023

    NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Fairfax, Virginia
      NEXT Virginia
    Sep 18, 2023

    Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumor
    • +7 more
    • WM-A1-3389
    • Pembrolizumab
    • Seoul, Seocho-gu, Korea, Republic of
    • +1 more
    May 14, 2023

    NSCLC Trial in Shanghai (BL-M02D1)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 10, 2023

    NSCLC Trial (Ivonescimab Injection, Pembrolizumab Injection)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Ivonescimab Injection
    • Pembrolizumab Injection
    • (no location specified)
    Jun 9, 2023

    NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University, Cancer Center
    Apr 14, 2023

    NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Mar 23, 2023

    Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • Utidelone Injection
    • Docetaxel Injection
    • (no location specified)
    Dec 30, 2022

    Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

    Not yet recruiting
    • Locally Advanced Alveolar Soft Part Sarcoma
    • +9 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 10, 2023

    Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Jul 12, 2023

    Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • (no location specified)
    Jan 12, 2023

    NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • MK-2870
    • +2 more
    • (no location specified)
    Oct 3, 2023

    Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

    Not yet recruiting
    • Lung Cancer
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jul 7, 2023

    Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

    Active, not recruiting
    Has Results
    • Metastatic Non-small Cell Lung Cancer
    • Metastatic Triple-negative Breast Cancer
    • ADV/HSV-tk
    • +3 more
    • Houston, Texas
      Houston Methodist Cancer Center
    Dec 28, 2022